0001437749-15-017258.txt : 20150914
0001437749-15-017258.hdr.sgml : 20150914
20150914191354
ACCESSION NUMBER: 0001437749-15-017258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150911
FILED AS OF DATE: 20150914
DATE AS OF CHANGE: 20150914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHLOSSBERG MARK A
CENTRAL INDEX KEY: 0001520533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 151106507
MAIL ADDRESS:
STREET 1: C/O IMPAX LABORATORIES, INC.
STREET 2: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-09-11
0001003642
IMPAX LABORATORIES INC
IPXL
0001520533
SCHLOSSBERG MARK A
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
1
SVP and General Counsel
Common Stock
2015-09-11
4
S
0
7457
43.30
D
73588
D
The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $43.24 to $43.38 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg
2015-09-14